Shilpa Therapeutics Private Limited

Shilpa Therapeutics Private Limited - pharma in Raichur, Karnataka, India. FY 2026 financials & compliance.
CIN U24239KA2004PTC176079 Incorporated 02 April 2004 ROC Bangalore HQ Raichur, Karnataka, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2023
₹4.45 Cr
▼ 34% YoY
Net loss · FY 2023
₹7.93 Cr
Net margin -178.2%
EBITDA · FY 2023
-₹3.23 Cr
EBITDA margin -72.6%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.24 Cr
Issued & subscribed
Satisfied charges
₹37.96 Cr
No open charges
Company age
22 yrs
Est. 2004
Employees · EPFO
24
Provident fund records

About Shilpa Therapeutics Private Limited

Data last updated:

Shilpa Therapeutics Private Limited is a private limited company based in Raichur, Karnataka, India, a subsidiary of Shilpa Medicare Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 2004 and has been in existence for over 22 years.

Its director Vishnukant Bhutada and family are #912 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2004PTC176079. Its GSTIN is 36AABCN9485A1ZE (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.24 Cr. It was formerly known as Nu Therapeutics Private Limited. It is led by directors Ramakant Innani and Vishnukanth Chaturbhuj Bhutada.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shilpa House #12 – 6 – 214/A1 Hyderabad Road, Raichur, Karnataka, India – 584135.

As per the financials filed for FY 2023, the company reported a revenue of ₹4.45 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹7.93 Cr (net margin -178.2%) and EBITDA of -₹3.23 Cr (EBITDA margin -72.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over five years.

The company has about 24 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Shilpa Therapeutics. As per MCA filings, the company has satisfied charges of ₹37.96 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.98 Cr; the latest was in May 2016. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Somu Chemicals and Pharmaceuticals Private Limited with revenue of ₹5.23 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2024, listing 37 overdue payments to 11 micro and small suppliers.

Shilpa Therapeutics Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0031108). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shilpatherapeutics.com.

Company details

CIN U24239KA2004PTC176079
Registration Number 176079
Incorporation Date 02 April 2004
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Shilpa Medicare Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0031108

CIN history

Shilpa Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239KA2004PTC176079, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239KA2004PTC176079Current
U24239AP2004PTC043005Previous
U24239TG2004PTC043005Previous
Key People
Ramakant Innani Director Vishnukanth Chaturbhuj Bhutada Nominee Director

Recognitions & Rankings of Shilpa Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-20-0031108

Contact details

Shilpa Therapeutics Private Limited's registered office is in Raichur, Karnataka. Its website is shilpatherapeutics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    shilpatherapeutics.com
  • Registered Address
    Shilpa House #12 – 6 – 214/A1 Hyderabad Road, Raichur, Karnataka, India – 584135
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Shilpa Therapeutics Private Limited, buy the company report.

Comprehensive company report
Shilpa Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Shilpa Therapeutics operates one associated brand: Shilpa Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Shilpa Therapeutics
Develops innovative technologies for orally disintegrating strips in pharmaceuticals.shilpatherapeutics.com

Financials of Shilpa Therapeutics Private Limited

FY 2025 filings available

Shilpa Therapeutics Private Limited reported revenue of ₹4.45 Cr (down 34% YoY) for FY 2023.

Revenue · FY 2023
₹4.45 Cr ▼ 34%
Net loss · FY 2023
₹7.93 Cr margin -178.2%
EBITDA · FY 2023
-₹3.23 Cr margin -72.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 34%
5 years · compounded
▲ 7%

Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹4.45 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3.23 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹7.93 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-72.6%
Net Profit Margin-178.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shilpa Therapeutics Private Limited, buy the company report.

Board of directors of Shilpa Therapeutics Private Limited

Shilpa Therapeutics has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ramakant Innani
Also directs: Shilpa Pharma Lifesciences Limited, Shilpa Biologicals Private Limited, Shilpa Lifesciences Private Limited and 5 more
Director07 Sep 201115 Years 1 MonthsCurrent
Vishnukanth Chaturbhuj Bhutada
Also directs: Ayodhya Sarayu Infra LLP, Shilpa Medicare Limited, Shilpa Pharma Lifesciences Limited and 5 more
Nominee Director07 Sep 201115 Years 1 MonthsCurrent
View all directors

Peer comparison

Shilpa Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Somu Chemicals and Pharmaceuticals Private Limited₹5.23 Cr (FY 2022)1.0%Bangalore, Karnataka, India
Fibroheal Woundcare Private Limited₹5.22 Cr (FY 2025)122.0%Doddaballapura, Karnataka, India
Malviya Chemicalsandpharmaceuticals Pvt Ltd₹5.19 Cr (FY 2025)-60.0%New Delhi, Delhi, India
Austin Pharmaceuticals Limited₹5.19 Cr (FY 2024)49.0%Chandigarh, India
Theta Pharmaceuticals Limited₹5.18 Cr (FY 2025)-8.0%Mumbai, Maharashtra, India
Shilpa Therapeutics Private Limitedthis company₹4.45 Cr (FY 2023)-₹7.93 Cr-178.2%-34.0%24Raichur, Karnataka, India

To see the full peer comparison of Shilpa Therapeutics Private Limited, buy the company report.

Auditor

Shilpa Therapeutics Private Limited is audited by SNM Nandury & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SNM Nandury & CoFY 20230061199S

Shareholding

The shareholding of Shilpa Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Shilpa Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹37.96 Cr
Breakdown by lending institutions
Citi Bank N.A.₹30.00 Cr
Bank of Baroda₹4.00 Cr
Axis Bank Limited₹2.00 Cr
Andhra Bank₹1.96 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 Apr 2020100334705Citi Bank N.A.₹25 CrSatisfied
16 Apr 2020100334706Citi Bank N.A.₹5 CrSatisfied
19 Dec 2016100075938Axis Bank Limited₹2 CrSatisfied
19 Dec 200710082699Bank of Baroda₹4 CrSatisfied
26 May 200710064033Andhra Bank₹70 LakhSatisfied

To see the full charge records of Shilpa Therapeutics Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Shilpa Therapeutics Private Limited has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.98 Cr; the latest was in May 2016.

Total deals
6
Funding rounds
5
Secondary share transfer
1
Disclosed funding
₹14.98 Cr

Deals on record (5 of 6)

WhenDealAmountParties
May 2016Secondary share transferUndisclosedBuyer: Shilpa Medicare Limited , Om Prakash Inani & Shilpa Medicare Limited
Seller: 4 individuals
Feb 2014Funding round₹40 LakhInvestors: Shilpa Medicare Limited
Jan 2010Funding round₹2 CrInvestors: Shilpa Medicare Limited , an individual
Nov 2009Funding round₹18.8 LakhInvestors: 3 individuals
Sep 2007Funding round₹2.02 CrInvestors: BBI Technologies Inc, 3 individuals

To see the full deal history of Shilpa Therapeutics Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Shilpa Therapeutics Private Limited has 5 MSME Form 1 returns on record between 2019 and 2024, listing 37 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 11)

SupplierAmount dueDue sinceReported on
an individual supplier
Sree Saanvi Poly Pack
Chrome Source
Trident Equipments Private Limited
Zodiac Reprographics Private Limited

To see the full MSME payment records of Shilpa Therapeutics Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Shilpa Therapeutics Private Limited has a workforce of 24 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
24
Active EPFO establishments
1
Employee growth
-56.36%

GST

Shilpa Therapeutics has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AABCN9485A1ZETelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Shilpa Therapeutics Private Limited, buy the company report.

Recent activity

Shilpa Therapeutics Private Limited has 11 board changes on record since 2011: 2 appointments and 9 cessations. The latest: Rajender Sunki Reddy ceased to be Nominee Director on 29 Nov 2022.

AGM
Shilpa Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shilpa Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge registered on 16 Apr 2020 via Charge ID 100334705 with Citi Bank N.A. was fully satisfied on 17 Aug 2023.
Charges
A charge registered on 16 Apr 2020 via Charge ID 100334706 with Citi Bank N.A. was fully satisfied on 17 Aug 2023.
Ceased
Rajender Sunki Reddy ceased to be Nominee Director.
Charges
A charge with Citi Bank N.A. of Rs. 25.00 Cr registered on 16 Apr 2020 with Charge ID 100334705 was modified on 06 Oct 2022.
Charges
A charge with Citi Bank N.A. of Rs. 5.00 Cr registered on 16 Apr 2020 with Charge ID 100334706 was modified on 06 Oct 2022.
Charges
A charge registered on 19 Dec 2016 via Charge ID 100075938 with Axis Bank Limited was fully satisfied on 30 Apr 2020.
Charges
A charge with Citi Bank N.A. amounted to Rs. 25.00 Cr with Charge ID 100334705 was registered on 16 Apr 2020.
Charges
A charge with Citi Bank N.A. amounted to Rs. 5.00 Cr with Charge ID 100334706 was registered on 16 Apr 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.00 Cr with Charge ID 100075938 was registered on 19 Dec 2016.
Ceased
Manohar Katakam ceased to be Director.

16 earlier events are in the company report.

News

Frequently asked questions

Shilpa Therapeutics is an active private limited company based in Raichur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 2004 (22+ years old) and is registered under CIN U24239KA2004PTC176079.

Shilpa Therapeutics has 2 current directors:

The latest financial statements of Shilpa Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Shilpa Therapeutics is 36AABCN9485A1ZE, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Shilpa Therapeutics is U24239KA2004PTC176079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shilpa Therapeutics has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Shilpa Therapeutics was incorporated on 02 April 2004, making it 22+ years old. It is registered with the Registrar of Companies, Bangalore.

Shilpa Therapeutics has 6 deals on record (5 funding rounds, 1 secondary share transfer), with disclosed funding of ₹14.98 Cr; the latest was in May 2016.

The peers of Shilpa Therapeutics by revenue are Somu Chemicals and Pharmaceuticals Private Limited, Fibroheal Woundcare Private Limited, Malviya Chemicalsandpharmaceuticals Pvt Ltd, Austin Pharmaceuticals Limited, Theta Pharmaceuticals Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rajender Sunki Reddy ceased to be Nominee Director on 29 Nov 2022. Manohar Katakam ceased to be Director on 06 Jun 2016. Srinivasa Rao Paturi ceased to be Director on 06 Jun 2016. Shilpa Therapeutics has 11 board changes on record in total.

Yes, Shilpa Therapeutics is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0031108).

Shilpa Therapeutics has 5 MSME Form 1 returns on record between 2019 and 2024, listing 37 overdue payments to 11 micro and small suppliers. The latest return was filed on 27 Apr 2024.